Guidance note on the development of vaccinia virus based vaccines against smallpox

Brussels, 01 July 2002

At the request of the European Commission, Enterprise DG, the Pharmaceuticals Unit, the EMEA and its Scientific Committee, the Committee for Proprietary Medicinal Products (CPMP) produced a guidance document Note for guidance on the development of vaccinia virus based vaccines against smallpox. This Note for Guidance will be updated as further experience is gained in the development and manufacture of second generation smallpox vaccines.

Guidance document note